-
Chemical available in other sizes
Please inquire size and price
-
Stock availability
Please Inquire
-
Cas number
1292841-28-1
-
Chemical s molecular weight
654.2
-
Chemical s main applications
A novel labelled squalene synthase inhibitor. Lapaquistat acetate decreased plasma cholesterol and triglyceride levels, by lowering lipoproteins containing apoB100. Treatment with Lapaquistat acetate increased collagen concentration and transformed coronary plaques into fibromuscular plaques. Lapaquistat acetate also suppressed the expression of matrix metalloproteinase-1 and plasminogen activator inhibitor-1 in the plaque and increased peripheral coenzyme Q10 levels. Antiarteriosclerotics.
-
Chemical s category
Amines, Chiral Reagents, Heterocycles, Inhibitors, Isotope Labelled Compounds, Pharmaceuticals, Intermediates & Fine Chemicals
-
Other name
1-[2-[(3R,5S)-1-[3-(Acetyloxy)-2,2-dimethylpropyl]-7-chloro-5-(2,3-dimethoxyphenyl)-1,2,3,5-tetrahydro-2-oxo-4,1-benzoxazepin-3-yl]acetyl]-4-piperidineacetic Acid-d9; (3R-trans)-1-[[1-[3-(acetyloxy)-2,2-dimethylpropyl]-7-chloro-5-(2,3-dimethoxyphenyl)-1,2,3,5-tetrahydro-2-oxo-4,1-benzoxazepin-3-yl]acetyl]-4-piperidineacetic Acid-d9; TAK 475-d9;
-
Chemical s formula
C33H32D9ClN2O9
-
Physical properties
No Data Available
-
Melting temperature
No Data Available
-
Boiling temperature
No Data Available
-
Chemical s soluble in
No Data Available
-
Stability conditions
No Data Available
-
Storage
No Data Available
-
